COEGIN Share Price Performance
SEK 5.32
1.31 (32.67%)
Price SEK 5.32
Share Pricen/a
Is Coegin Pharma (NGM:COEGIN) In A Good Position To Deliver On Growth Plans?
Sep 17
Coegin Pharma AB Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
COEGIN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Coegin Pharma AB Key Details
About COEGIN
- Founded
- 2005
- Employees
- 1
- CEO
- WebsiteView website
Coegin Pharma AB, a biotechnology company, engages in developing peptide-based products for hair growth and skin pigmentation in Sweden. The company develops Follicopeptide, a peptide designed to enhance hair growth; and NPP-4, a natural pigmentation peptide 4 works by facilitating the transport of melanin to the skin, mimicking the natural process that occurs during sun exposure or tanning beds. It is also developing FOL026, a drug candidate which is in preclinical trial for the treatment of myocardial infarction; AVX420, a drug candidate which is in preclinical trial for the treatment of leukemia; and AVX001, a drug candidate which is in phase 2 clinical development to treat both actinic keratosis and basal cell carcinoma. Coegin Pharma AB was founded in 2005 and is based in Lund, Sweden.
